The abilities of RA-Hyd-Me and RA-Sali to inhibit BACE-1, an enzyme involved in the production of Aβ, suggest that these compounds could reduce the formation of amyloid plaques, a hallmark of AD pathology. This evidence concerns the gene BACE1 and Alzheimer disease.